BridgeMD
New treatment option for Pancreatic Ductal Adenocarcinoma (PDAC)
Official title Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)
ClinicalTrials.gov ID: NCT06659705
What this study is testing
What is 68Ga-FAPI-46 for PET / CT scan?
68Ga-FAPI-46 for PET / CT scan is an investigational medicine, being studied as a potential treatment for pancreatic ductal adenocarcinoma (pdac).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Assessment of the relevance of a new medical imaging test, FAPI PET, which could detect progression or relapse earlier than other tests currently available. Ultimately, it could enable early forms of pancreatic cancer to be detected and used for screening.
- Phase 2: a mid-size study of how well it works
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Cyto/histologically proven PDAC
- Non-metastatic proven PDAC on recent (\< 1 month) CT-scan and MRI
- Concomitant enrollment in the HoMING prospective cohort (Sponsor: AP-HP, NCT04363983)
- Age \> 18 years old
- Affiliation to a social security scheme
You likely can't join if
- Protected adults (guardianship, curatorship or safeguarding justice)
- Pregnant or breastfeeding woman
- Women of childbearing potential not using one highly effective method of contraception
See the full eligibility criteria
- Cyto/histologically proven PDAC
- Non-metastatic proven PDAC on recent (\< 1 month) CT-scan and MRI
- Concomitant enrollment in the HoMING prospective cohort (Sponsor: AP-HP, NCT04363983)
- Age \> 18 years old
- Affiliation to a social security scheme
- Signed informed consent
- Protected adults (guardianship, curatorship or safeguarding justice)
- Pregnant or breastfeeding woman
- Women of childbearing potential not using one highly effective method of contraception
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Cloud, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Cloud, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.